Last reviewed · How we verify
Docetaxel, Capecitabine and Oxaliplatin
Docetaxel, Capecitabine and Oxaliplatin is a Small molecule drug developed by Asan Medical Center. It is currently in Phase 1 development.
At a glance
| Generic name | Docetaxel, Capecitabine and Oxaliplatin |
|---|---|
| Sponsor | Asan Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma (PHASE2)
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585) (PHASE3)
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension (PHASE3)
- A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer (PHASE2)
- Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer (PHASE3)
- A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors (PHASE1, PHASE2)
- Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer (PHASE2)
- NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Docetaxel, Capecitabine and Oxaliplatin CI brief — competitive landscape report
- Docetaxel, Capecitabine and Oxaliplatin updates RSS · CI watch RSS
- Asan Medical Center portfolio CI
Frequently asked questions about Docetaxel, Capecitabine and Oxaliplatin
What is Docetaxel, Capecitabine and Oxaliplatin?
Docetaxel, Capecitabine and Oxaliplatin is a Small molecule drug developed by Asan Medical Center.
Who makes Docetaxel, Capecitabine and Oxaliplatin?
Docetaxel, Capecitabine and Oxaliplatin is developed by Asan Medical Center (see full Asan Medical Center pipeline at /company/asan-medical-center).
What development phase is Docetaxel, Capecitabine and Oxaliplatin in?
Docetaxel, Capecitabine and Oxaliplatin is in Phase 1.
Related
- Manufacturer: Asan Medical Center — full pipeline